China’s Porton and Novartis to create biotech park in Mengeš

Novartis, the Swiss owner of the Ljubljana-based pharmaceutical company Lek, and its Chinese supplier Porton Pharma Solutions, will set up a biotechnological park in Mengeš, central Slovenia. Novartis will lease part of its vacant premises to Porton in what the N1 news portal reports will create 300 new jobs.

Porton is to lease about 900 square meters of office space, 4,140 square metres of labs for research and development and a production facility from Novartis.

"This will allow the company to create its own R&D facilities and production inside the Life Science Park Mengeš,...

Continue reading on: